Skip Navigation

Cardiovascular Research 1999 43(1):107-116; doi:10.1016/S0008-6363(99)00076-0
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Millington, W. R
Right arrow Articles by Nyquist-Battie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millington, W. R
Right arrow Articles by Nyquist-Battie, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart

William R Millingtona,*, David W Rosenthala, Can B Unala and Cynthia Nyquist-Battieb

aDepartment of Basic Medical Science, School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA
bDepartment of Health Science, College of Health, University of North Florida, Jacksonville, FL 32224, USA

* Corresponding author. Tel.: +1-816-235-2713; fax: +1-816-235-6517 wmillington{at}ccctr.umkc.edu

Objective: {alpha}-Melanocyte-stimulating hormone ({alpha}-MSH), β-endorphin and other pro-opiomelanocortin- (POMC) derived peptides have been detected in the heart, but it is uncertain whether they are synthesized by cardiomyocytes or by cardiac nerves innervating the heart. The objective of this study was to determine whether POMC peptides are synthesized by cardiomyocytes. Methods: Pro-opiomelanocortin peptides were localized in rat heart by immunohistochemistry using antisera against {alpha}-MSH, β-endorphin and {alpha}N-acetyl-β-endorphin, the predominant POMC peptides found in heart. Pro-opiomelanocortin mRNA was investigated by reverse transcription polymerase chain reaction (RT-PCR) using primers that discriminate between full-length POMC mRNA and a 5' truncated POMC transcript that is presumed to be non-functional. Results: {alpha}-Melanocyte-stimulating hormone, β-endorphin and {alpha}N-acetyl-β-endorphin immunoreactivities were localized in atrial myocytes, particularly in the atrial appendages, but not to a significant extent in ventricular myocytes. Cardiac nerves were not immunostained. Atrial natriuretic peptide (ANP) immunoreactivity was similarly distributed in the adult heart. In neonatal heart, POMC-peptide and ANP immunoreactivities were present in both atrial and ventricular myocytes. RT-PCR amplification showed that full-length POMC mRNA transcripts were present in both atrial and ventricular tissue and provide evidence that 5' truncated POMC mRNA is expressed in heart. Conclusions: These results support the hypothesis that cardiomyocytes synthesize POMC peptides.

KEYWORDS Atrial function; Gene expression; Hormones; Neurotransmitters; Ventricular function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
J. A Chalmers, S.-Y. J Lin, T. A Martino, S. Arab, P. Liu, M. Husain, M. J Sole, and D. D Belsham
Diurnal profiling of neuroendocrine genes in murine heart, and shift in proopiomelanocortin gene expression with pressure-overload cardiac hypertrophy
J. Mol. Endocrinol., September 1, 2008; 41(3): 117 - 124.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.